Eagle Bay Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Eagle Bay Advisors's LLY Position: Q2 2026 in Review
Eagle Bay Advisors increased its Eli Lilly (LLY) stake by 8.4% in Q2 2026, buying an estimated $56.2K and bringing the position to 706 shares worth $847K. The position accounts for 0.63% of the portfolio, ranked #33.
Eagle Bay Advisors first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Eagle Bay Advisors held 706 shares of Eli Lilly worth $847K as of Q2 2026.
- Eagle Bay Advisors bought 55 Eli Lilly shares in Q2 2026, an estimated $56.2K.
- Eli Lilly made up 0.63% of Eagle Bay Advisors's portfolio in Q2 2026, its #33 holding.
- Eagle Bay Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Eagle Bay Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.